Sort
40,608 grants matching “prostate cancer”
High Throughput Microscopy Assays to Identify Inhibitors of Metastasis
$396,325Sara A Courtneidge · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · CA
High Throughput Microscopy Assays to Identify Inhibitors of Metastasis
$396,325Sara A Courtneidge · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2009 · CA
The Role of CXCL12 Signaling in Obesity-Induced Prostate Cancer Progression
$396,302John Digiovanni · University Of Texas At Austin · R01 · FY2017 · CA
The Role of CXCL12 Signaling in Obesity-Induced Prostate Cancer Progression
$396,302John Digiovanni · University Of Texas At Austin · R01 · FY2018 · CA
The Role of CXCL12 Signaling in Obesity-Induced Prostate Cancer Progression
$396,302John Digiovanni · University Of Texas At Austin · R01 · FY2016 · CA
Core A: Pathobiology Core
$396,282Massimo F Loda · Columbia University Health Sciences · P01 · FY2025 · CA
Development of biophysical approaches to investigate high-resolution structure and dynamics of membrane proteins
$396,250Ayyalusamy Ramamoorthy · Florida State University · R35 · FY2025 · GM
Development of biophysical approaches to investigate high-resolution structure and dynamics of membrane proteins
$396,250Ayyalusamy Ramamoorthy · Florida State University · R35 · FY2024 · GM
INVESTIGATING THE LONG NONCODING RNA PLUTO-201 AS A DRIVER AND THERAPEUTIC TARGET IN PROSTATE CANCER
$396,250Regents Of The University Of California, San Francisco, The · · FY2017 · Department of the Army
DEVELOPMENT OF SMALL MOLECULE ACTIVATORS OF PROTEIN PHOSPHOTASE 2A SMAP FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
$396,250Case Western Reserve University · · FY2015 · Department of the Army
TARGETING METABOLIC ADAPTATION PATHWAYS TO INHIBIT PROGRESSION AND METASTASIS OF CASTRATION-RESISTANT PROSTATE CANCER
$396,249Health Research, Inc. · · FY2016 · Department of the Army
Impact of urologist practice organization and health policy on prostate cancer treatment, overtreatment and spending
$396,240Brent K. Hollenbeck · University Of Michigan At Ann Arbor · R01 · FY2017 · HS
CANCER SERO EPIDEMIOLOGY AMONG THE JAPANESE IN HAWAII
$396,237Kuakini Medical Center · R01 · FY2002 · CA
Daily Quantification of Cancer-Associated Exosomal miRNA in Patient Blood by Photonic Crystal-Enhanced Quantum Dot Emission
$396,237Andrew Michael Smith · University Of Illinois At Urbana-Champaign · R01 · FY2018 · CA
CLINICAL TRIAL: THE SELENIUM AND VITAMIN E CHEMOPREVENTION TRIAL (SELECT)
$396,181Rowan A Chlebowski · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · M01 · FY2008 · RR
Developing A Novel Combinatorial Therapy for Lethal Neuroendocrine Prostate Cancer
$396,130Ming Hui Chen · Duke University · R01 · FY2025 · CA
Molecular Mechanisms of Polyoma Induced Transformation
$396,128Thomas M Roberts · Dana-Farber Cancer Inst · R01 · FY2010 · CA
ANTITUMOR MECHANISMS &THERAPEUTIC EFFECTS OF VITAMIN D
$396,101University Of Pittsburgh At Pittsburgh · R01 · FY2001 · CA
Cancer Care and Outcomes for Disabled Medicare Patients
$396,092Beth Israel Deaconess Medical Center · R01 · FY2005 · CA
Prospective Studies of Diet and Cancer in Men and Women
$396,040Walter C. Willett · Harvard School Of Public Health · P01 · FY2009 · CA
Understanding Resistance to Next Generation Antiandrogens
$396,018Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Chlorotoxin as a Targeting Agent for Cancer Therapies
$396,000James M Olson · Fred Hutchinson Cancer Research Center · R01 · FY2015 · CA
Chlorotoxin as a Targeting Agent for Cancer Therapies
$396,000James M Olson · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA
OPTIMIZING TREATMENT OF ADVANCED PROSTATE CANCER AND EXPLOITING MECHANISMS DRIVING CASTRATION RESISTANCE
$396,000Fred Hutchinson Cancer Research Center · · FY2010 · Department of the Army
Chlorotoxin as a Targeting Agent for Cancer Therapies
$396,000James M Olson · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA